Clinical Trials Sponsored by Beth Israel Deaconess Medical Center

Total 1366 results

Beth Israel Medical Center
InterMune

Completed

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Hepatitis C

United States
Beth Israel Medical Center
Bayer

Terminated

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Prostate Cancer

United States
Beth Israel Medical Center
AstraZeneca

Terminated

Anxiety in Recovering Opiate Dependence

Generalized Anxiety Disorder | Comorbid Opiate Dependence in Remission | Status Post Methadone-Maintenance Treatment

United States
Beth Israel Deaconess Medical Center
Novartis; Dana-Farber Cancer Institute; Duke University

Completed

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma | Renal Cancer

United States
Duke University
Patient-Centered Outcomes Research Institute; Beth Israel Deaconess Medical...

Completed

Disease-Modifying Treatments for Myasthenia Gravis (PROMISE-MG)

Autoimmune Diseases | Neurological Disorder

United States, Canada
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy

Breast Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center

Completed

Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

Prostate Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Lymphoma | Multiple Myeloma | Acute Myelogenous Leukemia

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; American Heart Association

Recruiting

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

Breast Cancer

United States
Beth Israel Deaconess Medical Center
Bristol-Myers Squibb; Dana-Farber Cancer Institute

Active, not recruiting

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Prostate Cancer

United States
Beth Israel Deaconess Medical Center
Bristol-Myers Squibb; Dana-Farber Cancer Institute

Completed

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft Versus Host Disease

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; Puma Biotechnology, Inc.

Withdrawn

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center

Terminated

GVAX vs. Placebo for MDS/AML After Allo HSCT

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Terminated

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Colorectal Carcinoma

United States
Toni Choueiri, MD
Beth Israel Deaconess Medical Center

Completed

Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Newark Beth Israel Medical Center

Recruiting

SPG Block for Acute Pediatric Migraine

Migraine in Children | Migraine in Adolescence | Sphenopalatine Neuralgia

United States
Newark Beth Israel Medical Center

Completed

Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?

Sickle Cell Anemia Crisis

United States
Newark Beth Israel Medical Center

Unknown

Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome

Smoking | Acute Coronary Syndrome

United States
Beth Israel Deaconess Medical Center
Walter Reed Army Medical Center

Completed

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Prostate Cancer

United States
Beth Israel Deaconess Medical Center
Bristol-Myers Squibb; Dana-Farber Cancer Institute

Terminated

Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma

Multiple Myeloma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center

Terminated

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

T-cell Non-Hodgkin Lymphoma

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Terminated

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.

Completed

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Tel-Aviv Sourasky Medical Center
Beth Israel Deaconess Medical Center; Tel Aviv University

Unknown

Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder

Post-traumatic Stress Disorder (PTSD)

Israel
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Beth Israel Deaconess Medical Center

Completed

Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI); Dana-Farber Cancer Institute

Recruiting

Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients

Acute Myelogenous Leukemia

United States
Beth Israel Deaconess Medical Center
National Institute of Mental Health (NIMH)

Active, not recruiting

The Evolution of Memories Across Wake and Sleep

Sleep | Sleep Deprivation

United States
Beth Israel Deaconess Medical Center
National Institute of Nursing Research (NINR)

Completed

Aerosol Inhalation Treatment for Dyspnea - Patients

Dyspnea

United States
Boston Urogynecology Associates
Beth Israel Deaconess Medical Center; Mount Auburn Hospital

Unknown

Vaginal Estrogen for Asymptomatic Microscopic Hematuria

Asymptomatic Microscopic Hematuria

United States
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center; Mclean Hospital

Not yet recruiting

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Obesity | Appetitive Behavior

United States
Beth Israel Deaconess Medical Center
National Institute of Mental Health (NIMH)

Recruiting

What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia

Schizophrenia

United States
National and Kapodistrian University of Athens
Beth Israel Deaconess Medical Center

Recruiting

Long Term Effects of Weight Loss on Post-prandial Gut Hormone Responses and Meal Induced Thermogenesis

Morbid Obesity

Greece
Beth Israel Deaconess Medical Center
Society for Obstetric Anesthesia and Perinatology

Active, not recruiting

IV Ketorolac on Platelet Function Post-Cesarean Delivery (KetoPltAgg)

Postoperative Pain | Postpartum Hemorrhage | Blood Loss, Postoperative | Analgesia, Obstetrical | Coagulation Defect; Postpartum | Nonsteroidals (NSAIDs)Toxicity | Ketorolac Adverse Reaction

United States
Beth Israel Deaconess Medical Center
Massachusetts Institute of Technology; TriNetX, LLC

Active, not recruiting

Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

Pancreatic Adenocarcinoma | Predictive Cancer Model

United States
Beth Israel Deaconess Medical Center
National Institute of Nursing Research (NINR)

Completed

Aerosol Inhalation Treatment for Dyspnea

Healthy | Dyspnea

United States
Beth Israel Deaconess Medical Center
University of Aarhus; American Heart Association

Completed

Thiamine as an Adjunctive Therapy in Cardiac Surgery

Coronary Artery Bypass | Cardiac Surgical Procedures

United States
Beth Israel Deaconess Medical Center
National Institute of Mental Health (NIMH)

Completed

Cognitive Enhancement Therapy for Early-Stage Schizophrenia

Schizophrenia

United States
Beth Israel Deaconess Medical Center
National Center for Advancing Translational Sciences (NCATS)

Completed

Feasibility Electrical Stimulation Study for Visual Hallucinations

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Beth Israel Deaconess Medical Center
National Institute of General Medical Sciences (NIGMS)

Completed

Statin Therapy in Acute Influenza

Influenza

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI); Dana-Farber Cancer Institute

Completed

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Renal Cancer

United States
Beth Israel Deaconess Medical Center
Medical University of South Carolina; Erie County Medical Center

Completed

Kidney Paired Donation Video-Based Education Trial

Kidney Paired Donation

United States
Beth Israel Deaconess Medical Center
Massachusetts Institute of Technology; TriNetX, LLC

Active, not recruiting

Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

Predictive Cancer Model

United States
Beth Israel Deaconess Medical Center
National Institute of Mental Health (NIMH)

Completed

Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis (CLUES)

Psychosis

United States
Samuel Brown
Beth Israel Deaconess Medical Center

Unknown

Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2 (ECASSS-R2)

Septic Shock

United States
National and Kapodistrian University of Athens
Beth Israel Deaconess Medical Center

Completed

Comparison of Gastric Bypass and Sleeve Gastrectomy in Metabolic and Cardiovascular Indices

Morbid Obesity
Beth Israel Deaconess Medical Center
National Institute of Mental Health (NIMH)

Completed

Amino Acids, Serotonin, and Body Weight Regulation

Anorexia Nervosa

United States
Beth Israel Deaconess Medical Center

Completed

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

Hyperglycemia | Insulin Resistance

United States
Montefiore Medical Center
Beth Israel Medical Center

Completed

The Impact of Point-of-Care Ultrasound

Shock | Ultrasound
Beth Israel Deaconess Medical Center
Johns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca

Active, not recruiting

Olaparib In Metastatic Breast Cancer

Metastatic Breast Cancer | Invasive Breast Cancer | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | Somatic Mutation Breast Cancer (BRCA1) | Somatic Mutation Breast Cancer (BRCA2)

United States
Massachusetts General Hospital
Novartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

RAD001 in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States

Clinical Trials Sponsored by Beth Israel Deaconess Medical Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations